Beyond Seizures: Managing the Multisystem Symptoms of CDD
At a Glance
CDKL5 deficiency disorder affects much more than seizures. Children may need coordinated support for vision, feeding and digestion, sleep and breathing, movement, and growth, with caregivers and specialists monitoring urgent changes and adapting therapies to daily needs.
While seizures are often the first sign of CDKL5 Deficiency Disorder (CDD), the condition impacts nearly every system in the body. Because the CDKL5 protein is essential for overall brain development, its reduced function leads to a range of “non-seizure” symptoms that require a holistic, multidisciplinary approach to care [1][2]. Managing these symptoms is often just as critical to your child’s quality of life as controlling their seizures [3].
Cortical Visual Impairment (CVI)
One of the most common features of CDD is Cortical Visual Impairment (CVI), which affects a large majority of children with the disorder [4][5]. In CVI, the physical structures of the eyes may sometimes appear normal on a basic exam, but the brain has difficulty processing the visual information it receives [6].
- Impact on Development: Research shows a strong association between visual health and overall progress; children with more severe visual impairment often face greater challenges in reaching motor milestones like sitting or walking [5][7].
- What to Look For: You may notice your child has difficulty with “fixation” (holding their gaze on an object) or “tracking” (following a moving object), though these skills can sometimes be relatively preserved compared to other visual tasks [6].
- Management: Regular evaluations by a pediatric ophthalmologist (to check for structural eye disease) and a functional vision specialist are both essential [8]. These specialists can help you adapt your home and therapy activities—such as using high-contrast colors or moving toys—to make the most of your child’s vision [9].
Gastrointestinal and Feeding Challenges
Gastrointestinal (GI) issues are incredibly common in CDD and can significantly affect growth and comfort [10].
- Feeding and Swallowing: Many children experience dysphagia (difficulty swallowing), which increases the risk of aspiration (inhaling food or liquid into the lungs) [11][12]. Because of these challenges, some families consider a gastrostomy tube (G-tube) to ensure their child receives safe nutrition [13][2]. A G-tube is considered individually based on growth, hydration, safe swallowing, and family goals—not simply because a child has CDD.
- Constipation and Reflux: Severe, chronic constipation is a major concern for many children and adults with CDD [10]. Reflux and frequent vomiting are also common and can be worsened by certain anti-seizure medications or the ketogenic diet [14]. Urgent red flags that require assessment include choking with breathing difficulty, severe abdominal distension, or significant weight loss.
- Growth: Children with CDD often grow more slowly than their peers, particularly after age 4 [13]. Regular monitoring by a dietitian and gastroenterologist is necessary to manage these complex needs [2].
Sleep and Breathing Disturbances
Sleep and breathing issues warrant clinical attention and should not be dismissed as simply part of the disease.
- Insomnia and “Night Parties”: Parents frequently report prolonged “sleep latency” (taking a long time to fall asleep) and frequent nighttime wakings [15][16]. Some children experience periods of nighttime wakefulness where they may seem alert or even playful for hours, sometimes called “night parties” [17].
- Daytime Somnolence: Poor nighttime sleep often leads to excessive daytime sleepiness, which can interfere with therapy and learning [3][16].
- Breathing Irregularities: Abnormal breathing patterns while awake, such as hyperventilation (very fast breathing), have been observed in cohorts [15]. Separately, sleep-related breathing problems like obstructive sleep apnea or central apneas (brief pauses in breathing) can occur. If you notice gasping, snoring, or pauses in breathing during sleep, your doctor may recommend a polysomnography (sleep study) to properly check for sleep-disordered breathing [18].
Motor Function and Movement
Most children with CDD have hypotonia (low muscle tone), which makes it difficult to support their own weight or coordinate movements [4][10].
- Mobility: While development is typically slow, many children do gain milestones over time. In some observational cohorts, roughly 67% of females and 37% of males learned to sit independently by age 7, though fewer (about 25%) achieved independent walking [19]. These are cohort estimates and not absolute predictions for an individual child.
- Movement Disorders: Involuntary movements, such as hand-wringing or tremors, are common [4][20]. As children grow, monitoring for scoliosis (curvature of the spine) becomes a priority, as it is a frequent complication in older children and adults [10][2].
By addressing these multisystem symptoms alongside seizure care, you can help your child remain as comfortable, alert, and engaged as possible. This often requires a dedicated team of specialists, including gastroenterologists, physical therapists, and vision experts, working together with your neurologist [2][21].
Common questions in this guide
What symptoms can CDKL5 deficiency disorder cause besides seizures?
How can I support my child’s cortical visual impairment in daily life?
What feeding or digestive signs in CDD need prompt medical attention?
When might a child with CDD need a G-tube?
When should my child with CDD have a sleep study?
How are movement problems and scoliosis monitored in children with CDD?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How should we adapt our child's physical therapy and daily activities to account for their Cortical Visual Impairment (CVI)?
- 2.Is my child showing any signs of 'silent aspiration' during feeding that we might be missing?
- 3.Given the high rate of constipation in CDD, what is our long-term plan for managing my child's bowel health?
- 4.At what point should we consider a sleep study (polysomnography) to check for central apneas or other breathing issues?
- 5.How often should my child be screened for scoliosis or hip alignment issues as they grow?
- 6.Can we review my child's current medication list to see if any are contributing to their daytime sleepiness or gastrointestinal issues?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (21)
- 1
International Consensus Recommendations for the Assessment and Management of Individuals With CDKL5 Deficiency Disorder.
Amin S, Monaghan M, Aledo-Serrano A, et al.
Frontiers in neurology 2022; (13()):874695 doi:10.3389/fneur.2022.874695.
PMID: 35795799 - 2
Providing quality care for people with CDKL5 deficiency disorder: A European expert panel opinion on the patient journey.
Amin S, Møller RS, Aledo-Serrano A, et al.
Epilepsia open 2024; (9(3)):832-849 doi:10.1002/epi4.12914.
PMID: 38450883 - 3
Negative impact of insomnia and daytime sleepiness on quality of life in individuals with the cyclin-dependent kinase-like 5 deficiency disorder.
Downs J, Jacoby P, Saldaris J, et al.
Journal of sleep research 2022; (31(5)):e13600 doi:10.1111/jsr.13600.
PMID: 35415902 - 4
CDKL5 deficiency disorder and other infantile-onset genetic epilepsies.
Daniels C, Greene C, Smith L, et al.
Developmental medicine and child neurology 2024; (66(4)):456-468 doi:10.1111/dmcn.15747.
PMID: 37771170 - 5
CDKL5 deficiency disorder: Relationship between genotype, epilepsy, cortical visual impairment, and development.
Demarest ST, Olson HE, Moss A, et al.
Epilepsia 2019; (60(8)):1733-1742 doi:10.1111/epi.16285.
PMID: 31313283 - 6
Cortical Visual Impairment in CDKL5 Deficiency Disorder.
Quintiliani M, Ricci D, Petrianni M, et al.
Frontiers in neurology 2021; (12()):805745 doi:10.3389/fneur.2021.805745.
PMID: 35153983 - 7
Cerebral Visual Impairment in CDKL5 Deficiency Disorder Correlates With Developmental Achievement.
Brock D, Fidell A, Thomas J, et al.
Journal of child neurology 2021; (36(11)):974-980 doi:10.1177/08830738211019284.
PMID: 34547934 - 8
Cerebral visual impairment in CDKL5 deficiency disorder: vision as an outcome measure.
Olson HE, Costantini JG, Swanson LC, et al.
Developmental medicine and child neurology 2021; (63(11)):1308-1315 doi:10.1111/dmcn.14908.
PMID: 34028805 - 9
Initial Validation and Reliability of the CDKL5 Deficiency Disorder Hand Function Scale (CDD-Hand).
Saldaris J, Leonard H, Jacoby P, et al.
Journal of child neurology 2022; (37(6)):541-547 doi:10.1177/08830738221091044.
PMID: 35422141 - 10
The natural history of CDKL5 deficiency disorder into adulthood.
Aledo-Serrano A, Lewis-Smith D, Leonard H, et al.
medRxiv : the preprint server for health sciences 2025; doi:10.1101/2025.01.12.24318239.
PMID: 39867409 - 11
CDKL5 deficiency causes epileptic seizures independent of cellular mosaicism.
Takahashi S, Takeguchi R, Tanaka R, et al.
Journal of the neurological sciences 2022; (443()):120498 doi:10.1016/j.jns.2022.120498.
PMID: 36417806 - 12
Pneumonitis and pneumonia after aspiration.
Son YG, Shin J, Ryu HG
Journal of dental anesthesia and pain medicine 2017; (17(1)):1-12 doi:10.17245/jdapm.2017.17.1.1.
PMID: 28879323 - 13
Growth patterns in individuals with CDKL5 deficiency disorder.
Wong K, Davies G, Leonard H, et al.
Developmental medicine and child neurology 2024; (66(4)):469-482 doi:10.1111/dmcn.15777.
PMID: 37804112 - 14
Efficacy of ketogenic diet in CDKL5-related epilepsy: a single arm meta-analysis.
Zhang J, Ma J, Chang X, et al.
Orphanet journal of rare diseases 2022; (17(1)):385 doi:10.1186/s13023-022-02492-6.
PMID: 36274176 - 15
Long time polysomnographic sleep and breathing evaluations in children with CDKL5 deficiency disorder.
Hagebeuk EEO, Smits A, de Weerd A
Sleep medicine 2023; (103()):173-179 doi:10.1016/j.sleep.2023.02.003.
PMID: 36812861 - 16
Exploring sleep challenges in CDKL5 Deficiency Disorder.
Leonard H, Szepe E, Junaid M, et al.
Journal of neurodevelopmental disorders 2026; (18(1)).
PMID: 41484992 - 17
Baseline characteristics and feasibility of clinical outcome measures in CDKL5 deficiency disorder: The CANDID observational study.
Liogier d'Ardhuy X, , Cimms T, et al.
Epilepsia 2026; (67(4)):1703-1721 doi:10.1002/epi.70095.
PMID: 41531035 - 18
CDKL5 deficiency entails sleep apneas in mice.
Lo Martire V, Alvente S, Bastianini S, et al.
Journal of sleep research 2017; (26(4)):495-497 doi:10.1111/jsr.12512.
PMID: 28230307 - 19
Factors influencing the attainment of major motor milestones in CDKL5 deficiency disorder.
Wong K, Junaid M, Demarest S, et al.
European journal of human genetics : EJHG 2023; (31(2)):169-178 doi:10.1038/s41431-022-01163-1.
PMID: 35978140 - 20
Clinical manifestations and epilepsy treatment in Japanese patients with pathogenic CDKL5 variants.
Kobayashi Y, Tohyama J, Takahashi Y, et al.
Brain & development 2021; (43(4)):505-514 doi:10.1016/j.braindev.2020.12.006.
PMID: 33436160 - 21
Exploring neurodevelopment in CDKL5 deficiency disorder: Current insights and future directions.
Dell'Isola GB, Perinelli MG, Frulli A, et al.
Epilepsy & behavior : E&B 2025; (171()):110504 doi:10.1016/j.yebeh.2025.110504.
PMID: 40414190
This page is for informational purposes only and does not constitute medical advice. A child’s neurologist and multidisciplinary care team should guide evaluations and decisions about feeding, sleep, breathing, vision, movement, and nutrition.
Get notified when new evidence is published on CDKL5-deficiency disorder.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.